{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T09:30:35Z","timestamp":1778232635113,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:00:00Z","timestamp":1632182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:00:00Z","timestamp":1632182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1245\/s10434-021-10669-9","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T14:26:06Z","timestamp":1632234366000},"page":"873-882","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Outcomes Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy with and without Diaphragmatic Resection in Patients with Peritoneal Metastases"],"prefix":"10.1245","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4772-5477","authenticated-orcid":false,"given":"Andrei","family":"Nikiforchin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6151-5660","authenticated-orcid":false,"given":"Vadim","family":"Gushchin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2641-1564","authenticated-orcid":false,"given":"Michelle","family":"Sittig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9704-6547","authenticated-orcid":false,"given":"Ekaterina","family":"Baron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1560-9172","authenticated-orcid":false,"given":"Felipe","family":"Lopez-Ramirez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6337-5278","authenticated-orcid":false,"given":"Carol","family":"Nieroda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4132-9489","authenticated-orcid":false,"given":"Armando","family":"Sardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,21]]},"reference":[{"issue":"13","key":"10669_CR1","doi-asserted-by":"publisher","first-page":"4226","DOI":"10.1245\/s10434-014-3891-3","volume":"21","author":"S Ahmed","year":"2014","unstructured":"Ahmed S, Levine EA, Randle RW, et al. Significance of diaphragmatic resections and thoracic chemoperfusion on outcomes of peritoneal surface disease treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2014;21(13):4226\u201331.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10669_CR2","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1245\/s10434-014-4083-x","volume":"22","author":"B Franssen","year":"2015","unstructured":"Franssen B, Tabrizian P, Weinberg A, et al. Outcome of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on patients with diaphragmatic involvement. Ann Surg Oncol. 2015;22(5):1639\u201344.","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10669_CR3","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.1245\/s10434-016-5209-0","volume":"23","author":"TE Grotz","year":"2016","unstructured":"Grotz TE, Mansfield PF, Royal RE, et al. Intrathoracic chemoperfusion decreases recurrences in patients with full-thickness diaphragm involvement with mucinous appendiceal adenocarcinoma. Ann Surg Oncol. 2016;23(9):2914\u20139.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10669_CR4","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1245\/s10434-019-07797-8","volume":"27","author":"BJ Sullivan","year":"2020","unstructured":"Sullivan BJ, Bekhor EY, Carpiniello M, et al. Diaphragmatic peritoneal stripping versus full-thickness resection in CRS\/HIPEC: is there a difference? Ann Surg Oncol. 2020;27(1):250\u20138.","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10669_CR5","doi-asserted-by":"publisher","first-page":"4707","DOI":"10.21873\/anticanres.11025","volume":"36","author":"MZ Muallem","year":"2016","unstructured":"Muallem MZ, Almuheimid J, Richter R, Braicu EI, Osman S, Sehouli J. Diaphragmatic surgery in advanced ovarian, tubal and peritoneal cancer: a 7-year retrospective analysis of the Tumor Bank Ovarian Cancer Network. Anticancer Res. 2016;36(9):4707\u201313.","journal-title":"Anticancer Res."},{"issue":"10","key":"10669_CR6","doi-asserted-by":"publisher","first-page":"5917","DOI":"10.21873\/anticanres.12936","volume":"38","author":"B Singh","year":"2018","unstructured":"Singh B, Singh G, Pourgholami M, Alzahrani N, Morris DL. Long-term survival and propensity score matched outcomes of bilateral vs. unilateral diaphragm interventions in cytoreductive surgery plus intra-peritoneal chemotherapy. Anticancer Res. 2018;38(10):5917\u201321.","journal-title":"Anticancer Res."},{"key":"10669_CR7","doi-asserted-by":"publisher","first-page":"4676","DOI":"10.1245\/s10434-020-09505-3","volume":"28","author":"A Craus-Miguel","year":"2021","unstructured":"Craus-Miguel A, Segura-Sampedro JJ, Gonz\u00e1lez-Argent\u00e9 X, Morales-Soriano R. Diaphragmatic peritonectomy and full-thickness resection in CRS\/HIPEC may allow higher completeness of cytoreduction rates with a low rate of respiratory complications. Ann Surg Oncol. 2021;28:4676\u201382.","journal-title":"Ann Surg Oncol"},{"issue":"13","key":"10669_CR8","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1245\/s10434-014-3869-1","volume":"21","author":"W Jimenez","year":"2014","unstructured":"Jimenez W, Sardi A, Nieroda C, et al. Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2014;21(13):4218\u201325.","journal-title":"Ann Surg Oncol"},{"issue":"20","key":"10669_CR9","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","volume":"30","author":"TC Chua","year":"2012","unstructured":"Chua TC, Moran BJ, Sugarbaker PH, et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012;30(20):2449\u201356.","journal-title":"J Clin Oncol"},{"issue":"6","key":"10669_CR10","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.jamcollsurg.2006.08.024","volume":"203","author":"RG da Silva","year":"2006","unstructured":"da Silva RG, Sugarbaker PH. Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer. J Am Coll Surg. 2006;203(6):878\u201386.","journal-title":"J Am Coll Surg"},{"issue":"12","key":"10669_CR11","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.ejso.2015.08.172","volume":"41","author":"YR Huo","year":"2015","unstructured":"Huo YR, Richards A, Liauw W, Morris DL. Hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery (CRS) in ovarian cancer: a systematic review and meta-analysis. Eur J Surg Oncol. 2015;41(12):1578\u201389.","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"10669_CR12","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1245\/s10434-014-3978-x","volume":"22","author":"JH Helm","year":"2015","unstructured":"Helm JH, Miura JT, Glenn JA, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis. Ann Surg Oncol. 2015;22(5):1686\u201393.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10669_CR13","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/DCR.0000000000001003","volume":"61","author":"BK Paul","year":"2018","unstructured":"Paul BK, Ihemelandu C, Sugarbaker PH. Prior surgical score: an analysis of the prognostic significance of an initial nondefinitive surgical intervention in patients with peritoneal carcinomatosis of a colorectal origin undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy. Dis Colon Rectum. 2018;61(3):347\u201354.","journal-title":"Dis Colon Rectum"},{"issue":"12","key":"10669_CR14","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1002\/(SICI)1097-0142(19960615)77:12<2622::AID-CNCR28>3.0.CO;2-T","volume":"77","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Stephens AD, Averbach AM, et al. Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Cancer. 1996;77(12):2622\u20139.","journal-title":"Cancer"},{"issue":"1","key":"10669_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S1470-2045(05)70539-8","volume":"7","author":"PH Sugarbaker","year":"2006","unstructured":"Sugarbaker PH. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol. 2006;7(1):69\u201376.","journal-title":"Lancet Oncol"},{"issue":"2","key":"10669_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205\u201313.","journal-title":"Ann Surg"},{"issue":"123","key":"10669_CR17","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1002\/jso.26371","volume":"1","author":"A Nikiforchin","year":"2021","unstructured":"Nikiforchin A, Gushchin V, King MC, et al. Surgical and oncological outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a nonacademic center: 25-year experience. J Surg Oncol. 2021;1(123):1030\u201344.","journal-title":"J Surg Oncol"},{"issue":"4","key":"10669_CR18","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1245\/s10434-016-5738-6","volume":"24","author":"K Chouliaras","year":"2017","unstructured":"Chouliaras K, Levine EA, Fino N, Shen P, Votanopoulos KI. Prognostic factors and significance of gastrointestinal leak after cytoreductive surgery (CRS) with heated intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2017;24(4):890\u20137.","journal-title":"Ann Surg Oncol"},{"issue":"13","key":"10669_CR19","doi-asserted-by":"publisher","first-page":"3950","DOI":"10.1245\/s10434-018-6823-9","volume":"25","author":"MHA Choudry","year":"2018","unstructured":"Choudry MHA, Shuai Y, Jones HL, et al. Postoperative complications independently predict cancer-related survival in peritoneal malignancies. Ann Surg Oncol. 2018;25(13):3950\u20139.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10669_CR20","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1245\/s10434-019-07518-1","volume":"27","author":"NL Leigh","year":"2020","unstructured":"Leigh NL, Solomon D, Feingold D, et al. Improved survival with experience: a 10-year learning curve in hyperthermic intraperitoneal chemotherapy and cytoreductive surgery. Ann Surg Oncol. 2020;27(1):222\u201331.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10669_CR21","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/bjs5.50179","volume":"3","author":"S Hallam","year":"2019","unstructured":"Hallam S, Tyler R, Price M, Beggs A, Youssef H. Meta-analysis of prognostic factors for patients with colorectal peritoneal metastasis undergoing cytoreductive surgery and heated intraperitoneal chemotherapy. BJS Open. 2019;3(5):585\u201394.","journal-title":"BJS Open"},{"issue":"3","key":"10669_CR22","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S1055-3207(03)00026-7","volume":"12","author":"BJ Moran","year":"2003","unstructured":"Moran BJ, Cecil TD. The etiology, clinical presentation, and management of pseudomyxoma peritonei. Surg Oncol Clin N Am. 2003;12(3):585\u2013603.","journal-title":"Surg Oncol Clin N Am"},{"issue":"3","key":"10669_CR23","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/BF02523654","volume":"7","author":"SR Pestieau","year":"2000","unstructured":"Pestieau SR, Esquivel J, Sugarbaker PH. Pleural extension of mucinous tumor in patients with pseudomyxoma peritonei syndrome. Ann Surg Oncol. 2000;7(3):199\u2013203.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10669_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/00005382-200404000-00013","volume":"19","author":"BY Lee","year":"2004","unstructured":"Lee BY, Kim HS, Lee SH, et al. Pseudomyxoma peritonei: extraperitoneal spread to the pleural cavity and lung. J Thorac Imaging. 2004;19(2):123\u20136.","journal-title":"J Thorac Imaging."},{"issue":"5","key":"10669_CR25","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1245\/s10434-018-07091-z","volume":"26","author":"JD Beane","year":"2019","unstructured":"Beane JD, Wilson GC, Sutton JM, et al. Pleuropulmonary recurrence following cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for appendiceal Pseudomyxoma peritonei. Ann Surg Oncol. 2019;26(5):1429\u201336.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10669_CR26","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/jso.21230","volume":"99","author":"TC Chua","year":"2009","unstructured":"Chua TC, Yan TD, Yap ZL, Horton MD, Fermanis GG, Morris DL. Thoracic cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy for pseudomyxoma peritonei. J Surg Oncol. 2009;99(5):292\u20135.","journal-title":"J Surg Oncol"},{"key":"10669_CR27","doi-asserted-by":"crossref","unstructured":"Sugarbaker PH, Chang D, Stuart OA. Hyperthermic intraoperative thoracoabdominal chemotherapy. Gastroenterol Res Pract. 2012;2012:623417.","DOI":"10.1155\/2012\/623417"},{"key":"10669_CR28","doi-asserted-by":"publisher","first-page":"504","DOI":"10.15761\/ICST.1000198","volume":"3","author":"MPVC Doyle","year":"2016","unstructured":"Doyle MPVC, Davies S, Fermanis GG, Horton MD, et al. Cytoreductive surgery and heated intrathoracic chemotherapy for thoracic extension of pseudomyxoma peritonei. Integr Cancer Sci Therap. 2016;3:504\u20138.","journal-title":"Integr Cancer Sci Therap"},{"issue":"1","key":"10669_CR29","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1245\/s10434-018-6991-7","volume":"26","author":"Y Kawaguchi","year":"2019","unstructured":"Kawaguchi Y, Hanaoka J, Ohshio Y, et al. Patient survival after surgical management in intrathoracic Pseudomyxoma peritonei. Ann Surg Oncol. 2019;26(1):238\u201343.","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10669_CR30","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1245\/s10434-017-5821-7","volume":"24","author":"MA Schneider","year":"2017","unstructured":"Schneider MA, Eshmuminov D, Lehmann K. Major postoperative complications are a risk factor for impaired survival after CRS\/HIPEC. Ann Surg Oncol. 2017;24(8):2224\u201332.","journal-title":"Ann Surg Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-10669-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-021-10669-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-10669-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T15:12:01Z","timestamp":1641222721000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-021-10669-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,21]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10669"],"URL":"https:\/\/doi.org\/10.1245\/s10434-021-10669-9","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,21]]},"assertion":[{"value":"14 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest regarding the publication of this paper.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}